In this episode, we dive deep into the revolutionary role of AI in clinical trials and patient care with George Magrath, MD, an esteemed ophthalmologist and the CEO of a cutting-edge pharmaceutical company specializing in ophthalmic drug development. Dr. Magrath shares his expertise, having trained in ocular oncology at the renowned Wills Eye Hospital in Philadelphia.

Dr. Magrath shares the innovative ways AI is being used in clinical trials, from patient selection to the development of new eye care medications. He also discusses how AI can accelerate the availability of effective ocular treatments and address wealth inequality in US health care. Lastly, we'll look ahead to the future prospects of AI in transforming ophthalmic pharmaceutical developments.

Tune in to discover how AI is reshaping the landscape of eye care and improving patient outcomes!

The Four Eyes Podcast is brought to you by YoungOD Connect

Learn more about Dr. Magrath

Learn more about companies using revolutionary AI technology in the medical space: Voxeleron, Verana Health, RETINA-AI